Safe Therapeutics im Vergleich zu epiAgeLite Nutzung und Statistiken

SafeTherapeutics is a mobile application which inform individuals immediately about whether their drugs are causing adverse drug reactions (ADR). We created and used a patented unique database extracting adverse drug effect data from millions of documents. The database is updated quarterly, and all the underlying documentation can be supplied to each patient’s healthcare provider. The SafeTherapeutics Platform is the only patient or problem-centric search platform for the clinical management of problems with your medications. Individuals enter their symptoms or problems from easy-to-navigate dropdown lists. Medications are entered by typing a few letters using a smart search, scanning their prescription labels. Once loaded, a single click will produce a display of potential ADR relationships, with the results seen within seconds. Results are color-coded like a ‘traffic light’ and severe problems are clearly flagged. Once the search is completed, the search results can easily be forwarded to the healthcare provider with links to the actual data and scientific based content. We know you will make use of the SafeTherapeutics App and learn a great deal to guide your health and wellness. App's functionality is paid and subscription-based. There is no free basic functionality. Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

People age at different rates. Some “look” and “feel” older than their chronological age while others look younger than their chronological age. Our biological age is a better parameter of our health, well-being and life span than our chronological age. DNA is the hardware, genetics is the operating system, and DNA methylation and other epigenetic factors are the software that programs the genome. A paradigm shift in the search for biological age markers occurred with the discovery of the “epigenetic clock” by Horvath, which is based on the measurement of DNA methylation status at 500 strategic positions in DNA. Studies suggest that accelerated “epigenetic clock” might be associated with increased risk for several age-related chronic diseases such as cardiovascular disease and cancer at a later age (https://www.ncbi.nlm.nih.gov/pubmed/?term=epigenetic+clock+disease). However, this is still an open field and more studies are needed. Importantly, “epigenetics” is different from “genetics” and is potentially reversible by dietary interventions and lifestyle changes. Preliminary studies show that dietary changes can cause deceleration of the epigenetic clock in certain people (https://www.ncbi.nlm.nih.gov/pubmed/30350398), but this is still an open field. Our application is an opportunity to get the results of epigenetic age. At this stage, it has only informative content that allows you to study the result of your test and it is easy to handle. In the future, we are going to expand the functionality of this application by adding questionnaires. Disclaimer: This app is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on this app. If you think you may have a medical emergency, call your doctor or emergency services immediately.
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

Safe Therapeuticsvs. epiAgeLite Ranking-Vergleich

Vergleichen Sie Safe Therapeutics den Ranking-Trend der letzten 28 Tage mit epiAgeLite

Rang

Keine Daten verfügbar

Safe Therapeutics im Vergleich zu epiAgeLite Ranking im Ländervergleich

Vergleichen Sie Safe Therapeutics den Ranking-Trend der letzten 28 Tage mit epiAgeLite

Keine Daten zum Anzeigen

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
Safe Therapeutics VS.
epiAgeLite

Dezember 17, 2024